City Holding Co’s Quest Diagnostics DGX Stock Holding History

City Holding Co’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-38	Closed	-$7.45K	–	598
2026 Q1	$7.45K	Hold	38	–	–	﹤0.01%	490
2025 Q4	$6.59K	Buy	+38	New	+$6.92K	﹤0.01%	517
2014 Q4	–	Sell	-100	Closed	-$6K	–	436
2014 Q3	$6K	Buy	+100	New	+$6.16K	﹤0.01%	370

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

City Holding Co's DGX Position: Q2 2026 in Review

City Holding Co sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 38 shares — an estimated $7.45K sold.

City Holding Co first reported a position in DGX in Q3 2014 and held it in 3 quarters. The position peaked at $7.45K in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

City Holding Co reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
City Holding Co sold 38 Quest Diagnostics shares in Q2 2026, an estimated $7.45K.
City Holding Co first reported a position in Quest Diagnostics in Q3 2014 and held it in 3 quarters.
City Holding Co's Quest Diagnostics position peaked at $7.45K in Q1 2026.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on City Holding Co's 13F filing for Q2 2026, filed 10 Jul 2026.